Works by Wang, Bin‐Chao

Results: 7

Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 3, p. 635, doi. 10.1007/s00520-014-2405-y

By:

Wang, Zhen;
Yan, Hong-Hong;
Yang, Jin-Ji;
Wang, Bin-Chao;
Chen, Hua-Jun;
Zhou, Qing;
Xu, Chong-Rui;
Jiang, Ben-Yuan;
Wu, Yi-Long

Publication type:

Article

Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2018, v. 9, n. 9, p. 1093, doi. 10.1111/1759-7714.12791

By:

Kang, Jin;
Chen, Hua‐Jun;
Zhang, Xu‐Chao;
Su, Jian;
Zhou, Qing;
Tu, Hai‐Yan;
Wang, Zhen;
Wang, Bin‐Chao;
Zhong, Wen‐Zhao;
Yang, Xue‐Ning;
Chen, Zhi‐Hong;
Ding, Yan;
Wu, Xue;
Wang, Mei;
Fu, Jian‐Gang;
Yang, Zhenfan;
Zhang, Xian;
Shao, Yang W.;
Wu, Yi‐Long;
Yang, Jin‐Ji

Publication type:

Article

Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231167818

By:

Wang, Zhen;
Zhang, Xu-Chao;
Feng, Wei-Neng;
Zhang, Li;
Liu, Xiao-Qing;
Guo, Wei-Bang;
Deng, Yan-Ming;
Zou, Qing-Feng;
Yang, Jin-Ji;
Zhou, Qing;
Wang, Bin-Chao;
Chen, Hua-Jun;
Tu, Hai-Yan;
Yan, Hong-Hong;
Wu, Yi-Long

Publication type:

Article

Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 135, doi. 10.1016/j.cllc.2021.09.002

By:

Tu, Hai-Yan;
Li, Yang-Si;
Bai, Xiao-Yan;
Sun, Yue-Li;
Zheng, Ming-Ying;
Ke, E-E;
Liao, Ri-Qiang;
Jiang, Ben-Yuan;
Lin, Jia-Xin;
Huang, Jie;
Xu, Bing-Fei;
Yang, Jin-Ji;
Zhang, Xu-Chao;
Zhou, Qing;
Wang, Bin-Chao;
Chen, Hua-Jun;
Tong, Xiaoling;
Yu, Ruoying;
Wu, Xue;
Zhu, Dongqin

Publication type:

Article

Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).

Published in:

2021

By:

Li, Xiang-Meng;
Li, Wen-Feng;
Lin, Jun-Tao;
Yan, Hong-Hong;
Tu, Hai-Yan;
Chen, Hua-Jun;
Wang, Bin-Chao;
Wang, Zhen;
Zhou, Qing;
Zhang, Xu-Chao;
Su, Jian;
Chen, Rui-Lian;
Wu, Yi-Long;
Yang, Jin-Ji

Publication type:

journal article

Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma.

Published in:

Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1515

By:

Zhong, Yu‐Min;
Chen, Ji;
Jiang, Jie;
Zhou, Wen‐Bin;
Gao, Ling‐Ling;
Zhang, Shui‐Lian;
Yan, Wen‐Qing;
Chen, Yu;
Zhang, Dong‐Kun;
Lu, Dan‐Xia;
Lv, Zhi‐Yi;
Xie, Zhi;
Huang, Ying;
Guo, Wei‐Bang;
Wang, Bin‐Chao;
Yang, Jin‐Ji;
Yang, Xue‐Ning;
Wu, Yi‐Long;
Zhang, Xu‐Chao

Publication type:

Article

Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer.

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.660488

By:

Zhao, Ruocong;
Cui, Yuanbin;
Zheng, Yongfang;
Li, Shanglin;
Lv, Jiang;
Wu, Qiting;
Long, Youguo;
Wang, Suna;
Yao, Yao;
Wei, Wei;
Yang, Jie;
Wang, Bin-Chao;
Zhang, Zhenfeng;
Zeng, Hui;
Li, Yangqiu;
Li, Peng

Publication type:

Article